Impact of COVID-19 on emergency department management of stroke and STEMI. A narrative review von Banfield, W.H., Elghawy, O., Dewanjee, A., Brady, W.J.

Volltext

Observational Cohort Study of Immune Checkpoint Inhibitor Therapy for Anaplastic and Poorly Differentiated Thyroid Carcinoma von Elghawy, O., Sun, L.

Volltext

P1.13B.01 Lurbinectedin vs. Platinum Rechallenge in Extensive Stage Small Cell Lung Cancer after Platinum Doublet, A Multicenter Retrospective Study von Libre, M., Barsouk, A., Lu, M., Lessans, S., Elghawy, O., Yu, C., Goel, K., Wu, J., Bhatia, S., Cass, A., Marmarelis, M., Iams, W.

Volltext

EP.12A.19 Race May Affect Survival in 1L Patients with Metastatic Non-Small Cell Lung Cancer (mNSLC) Onegfr-Targeted Therapy von Barsouk, A., Elghawy, O., Yang, G., Heidlauf, A., Yu, C., Wang, L., Goel, K., Rushkin, L., Huang, A., Sun, L., Singh, A., Cohen, R.B., Aggarwal, C., Marmarelis, M., Langer, C.

Volltext

MO01.12 Association of Opioid Use with Survival in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitor Therapy von Mock, J., Wynter, E., Young, P., Sytov, A., Elghawy, O., Gentzler, R., Novicoff, W., Martin, L., Hall, R.

Volltext

Supplementary Material for: Complete response of Triple Negative Metaplastic Carcinoma of the Breast Using Pembrolizumab von A., Ladwa, O., Elghawy, A., Schroen, K., Abernathy, J., Schlefman, P., Dillon

Volltext bestellen